ELK1 and prostate cancer: It has been demonstrated that ELK1-shRNA expression in LNCaP prostate cancer cells does not decrease, rather does increase modestly, their proliferation in an androgen depleted condition and that androgen does not significantly induce the proliferation of LNCaP-ELK1-shRNA cells [19].